Chia‐Po Fu
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
-
- Cardiovascular Disease and Adiposity
- Cardiovascular Function and Risk Factors
Papers in
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Diabetes Treatment and Management 2
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Cardiovascular Disease and Adiposity 3
- Co-authors
- Wayne Huey‐Herng Sheu (20 shared papers)I‐Te Lee (20 shared papers)Shih‐Yi Lin (18 shared papers)Wen‐Jane Lee (17 shared papers)Kae‐Woei Liang (14 shared papers)Jun‐Sing Wang (16 shared papers)Chih-Tai Ting (3 shared papers)Wen-Lieng Lee (5 shared papers)
- Journals
- Clinica Chimica Acta (7 papers)Medicine (3 papers)PLoS ONE (3 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (3 papers)Diabetology & Metabolic Syndrome (2 papers)
- Partner nations
- TaiwanUnited StatesGermany
In The Last Decade
Chia‐Po Fu
29 papers receiving 466 citations
Peers
Comparison fields: 5 of 64
- Ophthalmology 57
- Cardiology and Cardiovascular Medicine 108
- Clinical Biochemistry 29
- Endocrinology, Diabetes and Metabolism 65
- Nephrology 26
Countries citing papers authored by Chia‐Po Fu
This map shows the geographic impact of Chia‐Po Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Po Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Po Fu more than expected).
Fields of papers citing papers by Chia‐Po Fu
This network shows the impact of papers produced by Chia‐Po Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Po Fu. The network helps show where Chia‐Po Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chia‐Po Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 71 | |
| 2 | 2011 | 36 | |
| 3 | 2019 | 32 | |
| 4 | 2013 | 32 | |
| 5 | 2015 | 30 | |
| 6 | 2016 | 27 | |
| 7 | 2012 | 25 | |
| 8 | 2011 | 21 | |
| 9 | 2014 | 21 | |
| 10 | 2018 | 16 | |
| 11 | 2014 | 15 | |
| 12 | 2017 | 13 | |
| 13 | 2012 | 13 | |
| 14 | 2014 | 12 | |
| 15 | 2017 | 12 | |
| 16 | 2017 | 12 | |
| 17 | 2014 | 11 | |
| 18 | 2021 | 9 | |
| 19 | 2012 | 9 | |
| 20 | 2017 | 9 |
About Chia‐Po Fu
Chia‐Po Fu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Nephrology and Epidemiology, having authored 29 papers that have together received 473 indexed citations. Recurring topics across this work include Nerve injury and regeneration (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Cardiovascular Disease and Adiposity (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Diabetes Treatment and Management (2 papers), Pain Mechanisms and Treatments (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Ophthalmology (57 citations), Cardiology and Cardiovascular Medicine (108 citations), Clinical Biochemistry (29 citations), Endocrinology, Diabetes and Metabolism (65 citations) and Nephrology (26 citations). Chia‐Po Fu has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Wayne Huey‐Herng Sheu, I‐Te Lee, Shih‐Yi Lin, Wen‐Jane Lee, Kae‐Woei Liang, Jun‐Sing Wang, Chih-Tai Ting, Wen-Lieng Lee, James P. DeLany and Erin E. Kershaw. Their work appears in journals such as Clinica Chimica Acta, Medicine, PLoS ONE, Clinical Chemistry and Laboratory Medicine (CCLM) and Diabetology & Metabolic Syndrome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.